← Back
F

$ Value

$2.0M

Shares

1,909

Price

$1K

Filed

Feb 3

Insider

Name

Van Naarden Jacob

Title

EVP,Pres LLY Oncology&HdCorpBD

CIK

0001661254

Roles

Officer

Transaction Details

Transaction Date

2026-02-01

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,761

Footnotes

The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Filing Info

Accession No.

0001661254-26-000002

Form Type

4

Issuer CIK

0000059478

Van Naarden Jacob's History

Date Ticker Type Value
2026-02-09 LLY A $5.1M
2026-02-01 LLY M $0
2026-02-01 LLY F $2.0M
2026-02-01 LLY M $0
2025-08-13 LLY $647K

Other Insiders at LLY (90d)

Insider Bought Sold Last
Sulzberger Gabrielle 2026-04-20
Alvarez Ralph 2026-04-20
Fyrwald J Erik 2026-04-20
LUCIANO JUAN R 2026-04-20
Ricks David A
President, Chair, and CEO
2026-02-09
Zakrowski Donald A
SVP, Finance, & CAO
2026-02-09
Van Naarden Jacob
EVP,Pres LLY Oncology&HdCorpBD
2026-02-09
Hakim Anat
EVP, GC & Secretary
2026-02-09
Skovronsky Daniel
EVP, CS&PO & Pres. LRL
2026-02-09
Montarce Lucas
EVP & CFO
2026-02-09
Jonsson Patrik
EVP & President, LLY Int'l
2026-02-09
Yuffa Ilya
EVP&Pres, LLY USA&Global Capab
2026-02-09
Rau Diogo
EVP & CIDO
2026-02-09
Hernandez Edgardo
EVP & Pres., Mfg. Operations
2026-02-09
Dozier Eric
EVP, Chief People Officer
2026-02-09
Custer Kenneth L.
EVP & President, Card Met Hlth
2026-02-09
Brown Adrienne S
EVP, President LLY Imm
2026-02-09